Playback speed
10 seconds
ASCO 2022 Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment for HER2+ Gastric and GEJ Adenocarcinoma
By
ASCO 2022 Conference Coverage
FEATURING
Daisuke Takahari
By
ASCO 2022 Conference Coverage
FEATURING
Daisuke Takahari
129 views
June 17, 2022
Login to view comments.
Click here to Login